**As of August 20, 2026, the CDC has confirmed 2,777 measles cases across 47 U.S. jurisdictions, already exceeding the full-year 2025 total of 2,289 and marking the highest annual count since 1991.** This surge stems primarily from declining MMR vaccination coverage—national kindergarten rates fell to approximately 92.5% for the 2025–26 school year amid record exemptions—creating susceptible clusters that sustain 36 ongoing or new outbreaks, with 94% of cases linked to them and 93–94% occurring in unvaccinated or unknown-status individuals. Recent acceleration, including 211 new cases in the latest weekly update (mostly in Pennsylvania and Ohio), highlights active transmission in hotspots like Pennsylvania (over 379 cases) and Utah (around 518–526). Hospitalization stands at 7%, with zero deaths reported so far. Weekly CDC updates, back-to-school mixing in August–September, and the November Pan American Health Organization review of elimination status (lost if continuous domestic transmission exceeds one year) represent key near-term data points that could influence further case counts through year-end.
สรุปจาก AI ทดลองที่อ้างอิงข้อมูลจาก Polymarket ไม่ใช่คำแนะนำในการเทรดและไม่มีผลต่อการตัดสินตลาดนี้ · อัปเดตแล้วผู้ป่วยโรคหัดในสหรัฐอเมริกาในปี 2026?
ผู้ป่วยโรคหัดในสหรัฐอเมริกาในปี 2026?
$7,852,895 ปริมาณ
$7,852,895 ปริมาณ
Dec 30, 2026
↑4.5k
63%
↑3k
99%
↑3.5k
94%
↑4k
86%
↑5k
48%
↑7.5k
13%
↑10k
7%
↑12.5k
6%
$7,852,895 ปริมาณ
$7,852,895 ปริมาณ
Dec 30, 2026
↑4.5k
$128 ปริมาณ
63%
↑3k
$91,425 ปริมาณ
99%
↑3.5k
$14,126 ปริมาณ
94%
↑4k
$235,701 ปริมาณ
86%
↑5k
$232,596 ปริมาณ
48%
↑7.5k
$185,571 ปริมาณ
13%
↑10k
$6,516,848 ปริมาณ
7%
↑12.5k
$350,733 ปริมาณ
6%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.**As of August 20, 2026, the CDC has confirmed 2,777 measles cases across 47 U.S. jurisdictions, already exceeding the full-year 2025 total of 2,289 and marking the highest annual count since 1991.** This surge stems primarily from declining MMR vaccination coverage—national kindergarten rates fell to approximately 92.5% for the 2025–26 school year amid record exemptions—creating susceptible clusters that sustain 36 ongoing or new outbreaks, with 94% of cases linked to them and 93–94% occurring in unvaccinated or unknown-status individuals. Recent acceleration, including 211 new cases in the latest weekly update (mostly in Pennsylvania and Ohio), highlights active transmission in hotspots like Pennsylvania (over 379 cases) and Utah (around 518–526). Hospitalization stands at 7%, with zero deaths reported so far. Weekly CDC updates, back-to-school mixing in August–September, and the November Pan American Health Organization review of elimination status (lost if continuous domestic transmission exceeds one year) represent key near-term data points that could influence further case counts through year-end.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
ตลาดเปิดเมื่อ: Feb 16, 2026, 11:51 AM ET
ปริมาณการซื้อขาย
$7,852,895วันสิ้นสุด
Dec 31, 2026ตลาดเปิดเมื่อ
Feb 16, 2026, 11:51 AM ETResolver
0x65070BE91...This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.**As of August 20, 2026, the CDC has confirmed 2,777 measles cases across 47 U.S. jurisdictions, already exceeding the full-year 2025 total of 2,289 and marking the highest annual count since 1991.** This surge stems primarily from declining MMR vaccination coverage—national kindergarten rates fell to approximately 92.5% for the 2025–26 school year amid record exemptions—creating susceptible clusters that sustain 36 ongoing or new outbreaks, with 94% of cases linked to them and 93–94% occurring in unvaccinated or unknown-status individuals. Recent acceleration, including 211 new cases in the latest weekly update (mostly in Pennsylvania and Ohio), highlights active transmission in hotspots like Pennsylvania (over 379 cases) and Utah (around 518–526). Hospitalization stands at 7%, with zero deaths reported so far. Weekly CDC updates, back-to-school mixing in August–September, and the November Pan American Health Organization review of elimination status (lost if continuous domestic transmission exceeds one year) represent key near-term data points that could influence further case counts through year-end.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
ปริมาณการซื้อขาย
$7,852,895วันสิ้นสุด
Dec 31, 2026ตลาดเปิดเมื่อ
Feb 16, 2026, 11:51 AM ETResolver
0x65070BE91...**As of August 20, 2026, the CDC has confirmed 2,777 measles cases across 47 U.S. jurisdictions, already exceeding the full-year 2025 total of 2,289 and marking the highest annual count since 1991.** This surge stems primarily from declining MMR vaccination coverage—national kindergarten rates fell to approximately 92.5% for the 2025–26 school year amid record exemptions—creating susceptible clusters that sustain 36 ongoing or new outbreaks, with 94% of cases linked to them and 93–94% occurring in unvaccinated or unknown-status individuals. Recent acceleration, including 211 new cases in the latest weekly update (mostly in Pennsylvania and Ohio), highlights active transmission in hotspots like Pennsylvania (over 379 cases) and Utah (around 518–526). Hospitalization stands at 7%, with zero deaths reported so far. Weekly CDC updates, back-to-school mixing in August–September, and the November Pan American Health Organization review of elimination status (lost if continuous domestic transmission exceeds one year) represent key near-term data points that could influence further case counts through year-end.
สรุปจาก AI ทดลองที่อ้างอิงข้อมูลจาก Polymarket ไม่ใช่คำแนะนำในการเทรดและไม่มีผลต่อการตัดสินตลาดนี้ · อัปเดตแล้ว
ระวังลิงก์ภายนอก
ระวังลิงก์ภายนอก
คำถามที่พบบ่อย